Liang Han
- Cancer Research top 0.5%
- Cancer-related molecular mechanisms research 26
- MicroRNA in disease regulation 6
- Molecular Biology top 5%
- RNA modifications and cancer 23
- RNA Research and Splicing 9
- Circular RNAs in diseases 7
- PI3K/AKT/mTOR signaling in cancer 4
- Oncology top 10%
- HER2/EGFR in Cancer Research 4
- Epidemiology top 10%
- Geriatrics and Gerontology top 10%
-
- Lung Cancer Treatments and Mutations 7
- Journals
- Nucleic Acids Research (1 paper)Journal of Biological Chemistry (1 paper)Nature Communications (1 paper)
- Partner nations
- ChinaUnited StatesEthiopia
In The Last Decade
Liang Han
54 papers receiving 2.9k citations
Hit Papers
Peers
Comparison fields: 5 of 95
- Cancer Research 2.2k
- Molecular Biology 2.5k
- Oncology 300
- Epidemiology 307
- Geriatrics and Gerontology 30
Countries citing papers authored by Liang Han
This map shows the geographic impact of Liang Han's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liang Han with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liang Han more than expected).
Fields of papers citing papers by Liang Han
This network shows the impact of papers produced by Liang Han. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liang Han. The network helps show where Liang Han may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Liang Han, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 9 | |
| 3 | 2024 | 10 | |
| 4 | 2022 | 65 | |
| 5 | 2022 | 29 | |
| 6 | 2021 | 7 | |
| 7 | 2019 | 33 | |
| 8 | 2019 | 24 | |
| 9 | 2018 | 100 | |
| 10 | 2017 | 79 | |
| 11 | 2016 | 39 | |
| 12 | 2015 | 81 | |
| 13 | 2015 | 86 | |
| 14 | 2015 | 34 | |
| 15 | 2014 | 226 | |
| 16 | 2014 | 68 | |
| 17 | 2013 | 42 | |
| 18 | 2012 | 1 | |
| 19 | 2012 | 29 | |
| 20 | 2005 | 40 |
About Liang Han
Liang Han is a scholar working on Cancer Research, Molecular Biology and Oncology, having authored 58 papers that have together received 2.9k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (26 papers), RNA modifications and cancer (23 papers), RNA Research and Splicing (9 papers), Lung Cancer Treatments and Mutations (7 papers), Circular RNAs in diseases (7 papers), MicroRNA in disease regulation (6 papers), PI3K/AKT/mTOR signaling in cancer (4 papers) and HER2/EGFR in Cancer Research (4 papers). The work is most often cited by research in Cancer Research (2.2k citations), Molecular Biology (2.5k citations) and Oncology (300 citations). Liang Han has collaborated with scholars based in China, United States and Ethiopia. Frequent co-authors include Erbao Zhang, Wei De, Dandan Yin, Tongpeng Xu, Xuezhi He, Rong Kong, Rui Xia, Jinfei Chen, Xiyi Lu and Xinxin Si. Their work appears in journals such as Nucleic Acids Research, Journal of Biological Chemistry and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.